Loading companies…
Loading companies…
United States · Biotech
Develops novel antibody treatments for immunological and inflammatory disorders
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $65M | Alexandria Venture — Role not disclosedAscenta Capital — Role not disclosedAtlas Venture — Role not disclosedDeep Track Capital — Role not disclosedFidelity — Role not disclosedGoldman Sachs — Role not disclosedJanus Henderson Investors — Role not disclosed |